ArticleJournal of thoracic disease2016

Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer.

Carles Escriu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.